<- Back to digest

Arthroscopy - 2026-09-17 - Journal Article

Hip Arthroscopy in Patients With Global Acetabular Overcoverage Shows Significant 5-Year Improvements but Poses a Higher Risk of Revision Surgery Compared With Matched Controls.

Quesada-Jiménez R, Maldonado-Rosales A, Bomma KS, Moore WM, Sugarman EP, Domb BG

retrospective cohortLOE IIIn = 204 (51 GO, 153 matched controls)Minimum 5 years

Topics

arthroplastyshoulder elbowsports
PMID: 42754812DOI: 10.1002/arj.70522View on PubMed ->

Key Takeaway

Hip arthroscopy for global acetabular overcoverage (LCEA ≥40° plus coxa profunda) achieves significant 5-year PRO improvements but carries a 2-fold increased relative risk of revision hip arthroscopy (15.69% vs 7.84%) compared to matched controls.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study evaluated minimum 5-year PROs after primary hip arthroscopy for FAI syndrome and labral tears in patients with global acetabular overcoverage (LCEA ≥40° plus coxa profunda) versus propensity-matched controls (LCEA 25–39°, no coxa profunda). Both groups achieved significant improvements across mHHS, NAHS, HOS-SS, VAS, and satisfaction scores, reaching MCID and PASS at similar rates. The GO cohort had a 2-fold higher revision hip arthroscopy rate (15.69% vs 7.84%, RR=2.00) with no significant difference in THA-free survivorship.

Key Limitation

The 12-year enrollment window without documented standardization of acetabular rim resection amount means variation in surgical technique likely contributes to the elevated revision rate and limits reproducibility of the findings.

Original Abstract

PURPOSE

To evaluate minimum 5-year patient-reported outcomes (PROs) after primary hip arthroscopy for femoroacetabular impingement syndrome and labral tears in patient with global acetabular overcoverage (GO), with a secondary comparison of outcomes to a propensity-matched control group without GO.

METHODS

Prospectively collected data was analyzed for all patients who underwent primary hip arthroscopy between 2008 and 2020. Patients were included if they completed the preoperative and minimum 5-year postoperative questionnaires for at least 1 of the following PROs: modified Harris Hip Score, Non-Arthritic Hip Score, Hip Outcome Score-Sport-Specific Subscale, Visual Analog Scale, and patient satisfaction or reaching an endpoint (revision hip arthroscopy or total hip arthroplasty). Patients with radiographic findings of GO on the anteroposterior pelvis radiograph (lateral center-edge angle ≥40°) and coxa profunda were included in the GO cohort and were propensity-matched to controls without coxa profunda and with a lateral center-edge angle between 25° and 39° in a 1:3 ratio based on age, sex, body mass index, acetabular Outerbridge grade, labral, and capsular treatment.

RESULTS

Two hundred four patients were included: 51 in the GO group and 153 matched controls. The GO cohort showed significant improvements across all PROs (P < .001). Compared with the control group, similar magnitudes of improvement and postoperative scores for all PROs were observed, reaching minimal clinically important difference and patient acceptable symptom state at similar rates. The GO group had a higher frequency of revision hip arthroscopy (15.69% vs 7.84%; relative risk = 2.00) with similar rates of total hip arthroplasty-free survivorship.

CONCLUSIONS

Hip arthroscopy for the treatment of femoroacetabular impingement syndrome and labral tears in patients with radiographic evidence of GO shows significant improvements in PROs at a minimum 5-year follow-up. However, it carries a 2-fold increased relative risk of revision hip arthroscopy compared with that of the control group.

LEVEL OF EVIDENCE

Level III, retrospective comparative case series.